{
    "study_accession": "SDY33",
    "actual_completion_date": null,
    "actual_enrollment": 116,
    "actual_start_date": null,
    "age_unit": "Years",
    "brief_description": "A prospective longitudinal study to determine biological mechanisms that underlie the immunosuppressed state associated with immunosuppressive regimens after renal transplantation.",
    "brief_title": "Impact of immunosuppressive regimens on protective immunity in renal transplant recipients",
    "clinical_trial": "N",
    "condition_studied": "Assessment of vaccine response in chronically immunosuppressed renal transplant patients.",
    "dcl_id": 2,
    "description": "A prospective longitudinal study comparing renal transplant patients with controls to determine the biological mechanisms that underlie the immunosuppressed state associated with immunosuppressive regimens after transplantation.",
    "doi": "10.21430/M3TJ6DJLEY",
    "endpoints": "<ol><li>HLA genotyping of enrolled subjects.</li><li>FCM experiment to measure frequency and phenotypic profile of B and T cell subsets in chronically immunosuppressed patients.</li><li>CD107A degranulation assay to assess numbers and function of antigen-specific memory T cells in chronic immunosuppression.</li><li>CFSE proliferation assay to assess numbers and function of antigen-specific memory T cells in chronic immunosuppression.</li><li>ELISPOT assay to assess memory B cell function in renal transplant patients with tacrolimus and sirolimus treatment.</li><li>ELISA serum antibody titers to assess memory B cell function in renal transplant patients with tacrolimus and sirolimus treatment.</li><li>Effects of chronic immunosuppression on dendritic cell function.</li><li>Microarray experiment to define the transcriptional signatures associated with specific immunosuppressive regimens.</li><li>Viral monitoring by PCR.</li></ol>",
    "gender_included": "Female, Male",
    "hypothesis": "Not provided.",
    "initial_data_release_date": "2013-04-10",
    "initial_data_release_version": "DR1",
    "intervention_agent": "\r",
    "latest_data_release_date": "2013-04-10",
    "latest_data_release_version": "DR1",
    "maximum_age": "  60.00",
    "minimum_age": "  21.00",
    "objectives": "<ol><li>To determine the effects of chronic immunosuppressive therapies on adaptive immunity: Effects on the phenotype and functional properties of T cell and B cell subsets and antigen-specific T cells.</li><li>To determine the effects of chronic immunosuppressive therapies on innate immunity, dendritic cell phenotype, function and TLR signaling.</li><li>To define the transcriptional signatures associated with specific immunosuppressive regimens.</li></ol>",
    "official_title": "Impact of immunosuppressive regimens on protective immunity in renal transplant recipients",
    "sponsoring_organization": "NIAID",
    "target_enrollment": null,
    "workspace_id": 3,
    "research_focus": [
        "Vaccine Response"
    ],
    "arm": [
        {
            "arm_accession": "ARM219",
            "description": "De novo Renal Transplant Patients, No Induction Therapy, Tacrolimus Maintenance",
            "name": "De novo transplant, No Induction, Tacrolimus Maintenance"
        },
        {
            "arm_accession": "ARM220",
            "description": "De novo Renal Transplant Patients, No Induction Therapy, Sirolimus Maintenance",
            "name": "De novo transplant, No Induction, Sirolimus Maintenance"
        },
        {
            "arm_accession": "ARM221",
            "description": "De novo Renal Transplant Patients, With Induction Therapy,  Tacrolimus Maintenance",
            "name": "De novo transplant, With Induction, Tacrolimus Maintenance"
        },
        {
            "arm_accession": "ARM222",
            "description": "De novo Renal Transplant Patients, With Induction Therapy, Sirolimus Maintenance",
            "name": "De novo transplant, With Induction, Sirolimus Maintenance"
        },
        {
            "arm_accession": "ARM223",
            "description": "De novo Renal Transplant Patients, With Induction, Efalizumab Maintenance",
            "name": "De novo transplant, With Induction, Efalizumab Maintenance"
        },
        {
            "arm_accession": "ARM224",
            "description": "Healthy donor (surgical) controls ",
            "name": "Donor (surgical) Controls "
        },
        {
            "arm_accession": "ARM225",
            "description": "Healthy controls ",
            "name": "Healthy Controls "
        }
    ],
    "personnel": [
        {
            "first_name": "Christian",
            "last_name": "Larsen",
            "organization": "Emory Transplant Center",
            "role_in_study": "Principal Investigator",
            "site_name": "\"Emory Transplant Center, GA\"\r"
        }
    ],
    "pubmed": [
        {
            "title": "Rapid cloning of high-affinity human monoclonal antibodies against influenza virus.",
            "journal": "Nature.",
            "month": "May",
            "year": "2008",
            "doi": "10.1038/nature06890. Epub 2008 Apr 30.",
            "pubmed_id": "18449194"
        },
        {
            "title": "Rapid generation of fully human monoclonal antibodies specific to a vaccinating antigen.",
            "journal": "Nat Protoc.",
            "month": "-",
            "year": "2009",
            "doi": "10.1038/nprot.2009.3.",
            "pubmed_id": "19247287"
        },
        {
            "title": "Broadly cross-reactive antibodies dominate the human B cell response against 2009 pandemic H1N1 influenza virus infection.",
            "journal": "J Exp Med.",
            "month": "Jan",
            "year": "2011",
            "doi": "10.1084/jem.20101352. Epub 2011 Jan 10.",
            "pubmed_id": "21220454"
        }
    ],
    "program": [
        {
            "program_name": "Immune Function and Biodefense in Children, Elderly, and Immunocompromised Populations",
            "contract_name": "Protective Immunity in Transplant Recipients"
        }
    ],
    "assay": [
        {
            "measurement_technique": "ELISPOT",
            "number_of_expsamples": 12
        },
        {
            "measurement_technique": "Flow Cytometry",
            "number_of_expsamples": 2223
        },
        {
            "measurement_technique": "HLA Typing",
            "number_of_expsamples": 113
        },
        {
            "measurement_technique": "Transcription profiling by array",
            "number_of_expsamples": 129
        }
    ],
    "subject": {
        "race": [
            {
                "race": "Asian",
                "count": 4
            },
            {
                "race": "Black or African American",
                "count": 41
            },
            {
                "race": "Not Specified",
                "count": 1
            },
            {
                "race": "White",
                "count": 70
            }
        ],
        "gender": [
            {
                "Female": 48
            },
            {
                "Male": 68
            }
        ]
    }
}
